Antioxidants · 2019 · 28 citations · 34 references
MedicineCardiologyInflammationMetabolomicsPreventive CardiologyAcute Coronary SyndromesCardiac BiomarkersCardiovascular DiseaseCoronary Artery DiseaseOxidative StressReactive Oxygen SpeciesAcute Coronary Syndrome BiomarkersBiomarkersMyocardial Ischemic EventsNitric OxideOxidative BiomarkersOxidative Stress BiomarkersOxidative Stress In Cardiovascular DiseaseRedox Biomarkers
BACKGROUND: Oxidative stress is crucial in the pathogenesis of atherosclerosis and acute myocardial infarction (AMI). Under the generic terms "oxidative stress" (OS), many biomarkers belonging to different pathways have been proposed. AIM: To compare the levels of recently proposed OS-related parameters in acute coronary syndromes (ACS) and stable coronary artery disease (CAD), to evaluate their effectiveness as additive risk or illness indicators of stable and acute ischemic events, and their response over time during the course of AMI. METHODS: ), and Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), were evaluated. Moreover, time response during AMI course (admission, and 6, 12, 18, 24, 36, and 48 hours after, T0-T6, respectively) and correlation with traditional cardiovascular (CV) risk factors (age, gender, hypertension, diabetes mellitus, dyslipidemia, smoking habit) were also assessed. RESULTS: decreased. Kinetics of LOX-1 during AMI shows that this biomarker boosts early during the acute event (T1 and T2) and then progressively decreases, being significantly lower from T0 to T6. Different OS-related biomarkers were differentially associated with CV risk factors and CAD or ACS presence. CONCLUSION: Differences in OS-related biomarkers (between groups, according to the response over time during AMI, and to the presence of CV risk factors) confirmed OS involvement in the transition from healthy status to stable CAD and ACS, although evidencing the heterogeneous nature of redox processes. In future, a multi-marker panel including different biomarkers and pathways of oxidative stress could be evaluated as an additive tool to be used in the CV prevention, diagnosis, patient stratification, and treatment.
34
Luciano Cominacini, A. Rigoni, Anna Fratta Pasini et al. · Journal of Biological Chemistry · 2001 · 338 citations · Full text